Peter J. Blankestijn
Impact in
- Nephrology top 0.05%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Parathyroid Disorders and Treatments
-
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Cardiovascular Health and Disease Prevention
- Heart Rate Variability and Autonomic Control
Papers in
- Nephrology 186
- Dialysis and Renal Disease Management 138
- Chronic Kidney Disease and Diabetes 51
- Parathyroid Disorders and Treatments 10
-
- Blood Pressure and Hypertension Studies 98
- Renin-Angiotensin System Studies 25
- Co-authors
- Michiel L. Bots (121 shared papers)Hein A. Koomans (30 shared papers)Gerry Ligtenberg (29 shared papers)Muriël P.C. Grooteman (68 shared papers)Menso J. Nubé (62 shared papers)Inge H. H. T. Klein (12 shared papers)P. Liam Oey (20 shared papers)Marinus A. van den Dorpel (44 shared papers)
- Journals
- Nephrology Dialysis Transplantation (88 papers)Journal of Hypertension (20 papers)Clinical Kidney Journal (19 papers)Kidney International (18 papers)Journal of the American Society of Nephrology (17 papers)
- Partner nations
- NetherlandsItalyUnited Kingdom
In The Last Decade
Peter J. Blankestijn
386 papers receiving 15.1k citations
Peter J. Blankestijn's Hit Papers
Peers
Comparison fields: 5 of 149
- Nephrology 6.7k
- Cardiology and Cardiovascular Medicine 5.2k
- Emergency Medical Services 1.3k
- Transplantation 308
- Family Practice 90
Countries citing papers authored by Peter J. Blankestijn
This map shows the geographic impact of Peter J. Blankestijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Blankestijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Blankestijn more than expected).
Fields of papers citing papers by Peter J. Blankestijn
This network shows the impact of papers produced by Peter J. Blankestijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Blankestijn. The network helps show where Peter J. Blankestijn may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter J. Blankestijn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 399 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial Hit paper breakdown → | 2018 | 555 |
| 2 | Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes Hit paper breakdown → | 2012 | 415 |
| 3 | 2012 | 372 | |
| 4 | 1999 | 356 | |
| 5 | Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Hit paper breakdown → | 2020 | 354 |
| 6 | 2002 | 311 | |
| 7 | Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials Hit paper breakdown → | 2019 | 310 |
| 8 | Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial Hit paper breakdown → | 2021 | 302 |
| 9 | Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Hit paper breakdown → | 2019 | 301 |
| 10 | 2008 | 297 | |
| 11 | Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies Hit paper breakdown → | 2019 | 272 |
| 12 | 2004 | 247 | |
| 13 | 2018 | 246 | |
| 14 | 2015 | 232 | |
| 15 | 2018 | 231 | |
| 16 | Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes Hit paper breakdown → | 2023 | 215 |
| 17 | 2013 | 211 | |
| 18 | 2001 | 196 | |
| 19 | Classification of Uremic Toxins and Their Role in Kidney Failure Hit paper breakdown → | 2021 | 196 |
| 20 | 2004 | 172 |
About Peter J. Blankestijn
Peter J. Blankestijn is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Emergency Medical Services, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging, having authored 399 papers that have together received 15.9k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (138 papers), Blood Pressure and Hypertension Studies (98 papers), Chronic Kidney Disease and Diabetes (51 papers), Central Venous Catheters and Hemodialysis (34 papers), Renin-Angiotensin System Studies (25 papers), Dementia and Cognitive Impairment Research (13 papers), Advanced MRI Techniques and Applications (11 papers) and Parathyroid Disorders and Treatments (10 papers). The work is most often cited by research in Nephrology (6.7k citations), Cardiology and Cardiovascular Medicine (5.2k citations), Emergency Medical Services (1.3k citations), Transplantation (308 citations) and Family Practice (90 citations). Peter J. Blankestijn has collaborated with scholars based in Netherlands, Italy and United Kingdom. Frequent co-authors include Michiel L. Bots, Hein A. Koomans, Gerry Ligtenberg, Muriël P.C. Grooteman, Menso J. Nubé, Inge H. H. T. Klein, P. Liam Oey, Marinus A. van den Dorpel, Piet M. ter Wee and Erik Lars Penne. Their work appears in journals such as Nephrology Dialysis Transplantation, Journal of Hypertension, Clinical Kidney Journal, Kidney International and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.